Dana Farber Cancer Inst. — Boston, Massachusetts

Dana Farber Cancer Inst. is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Inst. has participated in 14 clinical trials with 1 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer, Non-Squamous Non-Small Cell Lung Cancer, Pancreatic Neoplasms.

Sponsors: Genentech, Inc., Hoffmann-La Roche, Nuvation Bio Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Inst.?

Dana Farber Cancer Inst. has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Inst. conducted?

Dana Farber Cancer Inst. has 14 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer, Non-Squamous Non-Small Cell Lung Cancer, Pancreatic Neoplasms.

Is Dana Farber Cancer Inst. accredited by Crixeo Health?

Yes — Dana Farber Cancer Inst. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Dana Farber Cancer Inst.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.